Package 63323-562-15

Brand: bivalirudin

Generic: bivalirudin
NDC Package

Package Facts

Identity

Package NDC 63323-562-15
Digits Only 6332356215
Product NDC 63323-562
Description

10 VIAL, SINGLE-USE in 1 CARTON (63323-562-15) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (63323-562-41)

Marketing

Marketing Status
Marketed Since 2017-10-30
Brand bivalirudin
Generic bivalirudin
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "c6dcd639-86b8-40e0-b18b-e2d4393f274b", "openfda": {"nui": ["N0000175980", "N0000175518", "N0000009963"], "upc": ["0363323562410"], "unii": ["TN9BEX005G"], "rxcui": ["308769"], "spl_set_id": ["50975be1-6d1f-497c-b989-1825a0fae1a7"], "pharm_class_epc": ["Anti-coagulant [EPC]", "Direct Thrombin Inhibitor [EPC]"], "pharm_class_moa": ["Thrombin Inhibitors [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-USE in 1 CARTON (63323-562-15)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (63323-562-41)", "package_ndc": "63323-562-15", "marketing_start_date": "20171030"}], "brand_name": "Bivalirudin", "product_id": "63323-562_c6dcd639-86b8-40e0-b18b-e2d4393f274b", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Anti-coagulant [EPC]", "Direct Thrombin Inhibitor [EPC]", "Thrombin Inhibitors [MoA]"], "product_ndc": "63323-562", "generic_name": "Bivalirudin", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bivalirudin", "active_ingredients": [{"name": "BIVALIRUDIN", "strength": "250 mg/1"}], "application_number": "ANDA090189", "marketing_category": "ANDA", "marketing_start_date": "20171030", "listing_expiration_date": "20261231"}